Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | FABP4 | P15090 | 1/20 | 0.33 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1034997 | 0.90 | KDM4E (0.40) | KDM4EL3MBTL1FABP4HPGDMEN1 | |
| SCHEMBL17819098 | 0.81 | TAS1R3 (0.36) | KDM4EL3MBTL1FFAR4CRHR1MEN1 | |
| SCHEMBL1037184 | 0.74 | LMNA (0.38) | KDM4EL3MBTL1HPGDMEN1LMNA | |
| SCHEMBL20636994 | 0.73 | NPSR1 (0.40) | KDM4EL3MBTL1FFAR1FFAR4FABP4 | |
| SCHEMBL1035817 | 0.72 | KDM4E (0.37) | KDM4EL3MBTL1HPGDMEN1LMNA | |
| SCHEMBL1037385 | 0.72 | KMT2A (0.46) | KDM4EL3MBTL1HPGDMEN1LMNA | |
| SCHEMBL1034451 | 0.71 | NLRP3 (0.45) | KDM4EL3MBTL1HPGDMEN1LMNA | |
| SCHEMBL1037277 | 0.71 | LMNA (0.37) | KDM4EL3MBTL1HPGDMEN1LMNA | |
| SCHEMBL12956843 | 0.71 | HPGD (0.37) | KDM4EL3MBTL1GPR84FFAR1CRHR1 | |
| SCHEMBL16401203 | 0.71 | KDM4E (0.33) | KDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3019508-B1 | LIQUID BISACYLPHOSPHINE OXIDE PHOTOINITIATOR | IGM GROUP B V (NL) | 2019-01-30 | — | — | EP | disclosed |
| US-9796740-B2 | Liquid bisacylphosphine oxide photoinitiator | BASF SE (DE) | 2017-10-24 | — | — | US | disclosed |
| US-20160168177-A1 | LIQUID BISACYLPHOSPHINE OXIDE PHOTOINITIATOR | IGM GROUP B.V. (NL) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168177-A1 | LIQUID BISACYLPHOSPHINE OXIDE PHOTOINITIATOR | CCNY, CCNT2, CCNE2 | KDM4E 2420/4885L3MBTL1 936/4885GPR84 1073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.